Avadel Pharmaceuticals Plc (AVDL)
21.64
0.00 (0.00%)
USD |
NASDAQ |
Sep 01, 16:00
Avadel Pharmaceuticals Cash and Short Term Investments (Quarterly) : 91.58M for Sept. 30, 2025
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | 91.58M |
| June 30, 2025 | 81.55M |
| March 31, 2025 | 66.48M |
| December 31, 2024 | 73.78M |
| September 30, 2024 | 65.81M |
| June 30, 2024 | 71.38M |
| March 31, 2024 | 88.79M |
| December 31, 2023 | 105.11M |
| September 30, 2023 | 153.18M |
| June 30, 2023 | 160.51M |
| March 31, 2023 | 100.92M |
| December 31, 2022 | 96.50M |
| September 30, 2022 | 106.48M |
| June 30, 2022 | 104.12M |
| March 31, 2022 | 123.48M |
| December 31, 2021 | 157.22M |
| September 30, 2021 | 181.09M |
| June 30, 2021 | 202.84M |
| March 31, 2021 | 204.98M |
| December 31, 2020 | 221.40M |
| September 30, 2020 | 231.58M |
| June 30, 2020 | 238.55M |
| March 31, 2020 | 113.48M |
| December 31, 2019 | 64.16M |
| September 30, 2019 | 72.45M |
| Date | Value |
|---|---|
| June 30, 2019 | 79.26M |
| March 31, 2019 | 79.85M |
| December 31, 2018 | 99.92M |
| September 30, 2018 | 125.26M |
| June 30, 2018 | 147.11M |
| March 31, 2018 | 198.18M |
| December 31, 2017 | 94.08M |
| September 30, 2017 | 115.61M |
| June 30, 2017 | 173.80M |
| March 31, 2017 | 179.21M |
| December 31, 2016 | 154.20M |
| September 30, 2016 | 149.67M |
| June 30, 2016 | 154.86M |
| March 31, 2016 | 159.95M |
| December 31, 2015 | 144.80M |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | 113.17M |
| December 31, 2014 | 92.83M |
| September 30, 2014 | 76.50M |
| June 30, 2014 | 77.86M |
| March 31, 2014 | 83.52M |
| December 31, 2013 | 7.037M |
| September 30, 2013 | 9.28M |
| June 30, 2013 | 9.723M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Jazz Pharmaceuticals Plc | 2.200B |
| Perrigo Co. Plc | 399.70M |
| GH Research Plc | 362.65M |
| Cosmo NV | -- |
| Alkermes Plc | 656.58M |